Calvin Scott Recalls Phentermine Capsules Due to Packaging Defect
Calvin Scott & Co. is recalling specific lots of Phentermine HCL capsules because they were repackaged in transparent pouches, violating CGMP requirements for light-sensitive drugs.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically indicates a violation of CGMP that may cause temporary or medically reversible health consequences. The specific hazard is packaging-related (light sensitivity) rather than a high-risk pathogen or structural defect, fitting the Moderate severity criteria for minor labeling/packaging errors or low-risk contamination.
Plain-English summary
Calvin Scott & Company, Inc. is recalling specific lots of Phentermine HCL Gray/Yellow capsules, 15mg, 28-count bags. The recall is due to Current Good Manufacturing Practice (CGMP) deviations where light-sensitive drug products were repackaged in transparent or partially transparent pouches.
The affected products are distributed nationwide within the United States. The specific lots involved are 19189 (Expiration Date: 08/20), 19272 (Expiration Date: 9/20), and 19323 (Expiration Date: 9/20). The products are manufactured by Kvk-Tech and distributed by Calvin Scott & Co., Inc. in Albuquerque, NM.
Consumers should check their medication for the NDC 10702-0026-10 and the lot numbers listed above. If the product matches these details, it should be returned to the pharmacy or point of purchase for disposal or replacement.
The recalled product
- Product
- Phentermine HCL Gray/Yellow capsules, 15mg, 28-count bags, Rx only, Distributed by: Calvin Scott & Co., Inc. Albuquerque, NM 87123 Manufactured by Kvk-Tech, NDC 10702-0026-10
- Manufacturer
- Calvin Scott & Company, Inc.
- Category
- Drug — Prescription Medication
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot #: 19189
- Exp. Date: 08/20
- 19272
- 19323
- Exp. Date: 9/20
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 19 recalled by Calvin Scott & Company, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 19 products in this recall →Related recalls
Same manufacturer · Calvin Scott & Company, Inc.
See all →- ModerateBenzphetamine tablets recalled due to label mix-up with Benzonatate
FDA (Drugs) · 2022-06-01
- SevereBenzonatate 100mg Capsules Label Mix-up — Wrong Medication in Bottles
FDA (Drugs) · 2022-06-01
- ModerateCalvin Scott Recalls Diethylpropion Tablets Due to Stability Deviations
FDA (Drugs) · 2020-10-14
- ModerateCalvin Scott Recalls Diethylpropion Tablets Due to Missing Stability Studies
FDA (Drugs) · 2020-10-14
- ModerateCalvin Scott Recalls Phentermine Capsules Due to Stability Study Deviations
FDA (Drugs) · 2020-10-14
Same hazard · packaging defect
See all →- HighMD Wipe Outz Numbing Tattoo Wipes Recalled for Child Poisoning Risk
CPSC · 2026-08-27
- HighV-Loc 90 Absorbable Wound Closure Devices Recalled for Packaging Defects
FDA (Devices) · 2026-08-19
- SevereDermalon Sutures Recalled for Potential Sterile Barrier Packaging Defects
FDA (Devices) · 2026-08-19
- HighV-Loc 180 Absorbable Wound Closure Device Recalled for Packaging Defects
FDA (Devices) · 2026-08-19
- HighBiopsy Forceps Recall: Sterile Packaging Breach Risk
FDA (Devices) · 2026-08-12